Dual inhibition of MET and SRC kinase activity as a combined targeting strategy for colon cancer

Hepatocyte growth factor (HGF)/MET signaling is implicated in the development of colorectal cancer (CRC) and possesses therapeutic value for various types of cancer. However, inhibition of MET alone has been demonstrated to have limited efficacy. The present study examined the combined inhibition of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Exp Ther Med
Main Authors: Song, Na, Qu, Xiujuan, Liu, Shizhou, Zhang, Simeng, Liu, Jing, Qu, Jinglei, Zheng, Huachuan, Liu, Yunpeng, Che, Xiaofang
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5526150/
https://ncbi.nlm.nih.gov/pubmed/28810597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2017.4692
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados